Document is current
Any future updates will be listed below
-
Authors
Rapoport, Alan M. http://orcid.org/0000-0002-6311-8562
Lipton, Richard B. http://orcid.org/0000-0003-2652-2897
- License Information
-
More Information
Article History
First Online: 26 May 2021
Competing interests
: A.M.R. serves as an advisor for AbbVie, Amgen, Biohaven, Cala Health, Novartis, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano; he is on the speaker bureau of AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. R.B.L. receives research support from the NIH and FDA as well as the National Headache Foundation and the Marx Foundation. He also receives research support from Allergan/Abbvie, Amgen, Biohaven Holdings, Eli Lilly and Electrocore. He receives personal fees as a consultant or advisor from Allergan/Abbvie, Amgen, Biohaven Holdings, Dr. Reddy’s, GlaxoSmithKline, Grifols, Impel NeuroPharma, Lundbeck, Merck, Novartis and Teva Pharmaceuticals. He holds stock or options in Biohaven Holdings and CtrlM Health. In addition, he receives royalties for Wolff’s Headache 7th and 8th Edition.
